Detalhe da pesquisa
1.
Reduced risk of suicidal behaviours associated with the treatment of hidradenitis suppurativa with tumour necrosis factor alpha antagonists: results from the US FDA Adverse Events Reporting System pharmacovigilance database.
J Eur Acad Dermatol Venereol
; 34(7): 1564-1568, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981260
2.
Response to Raschi E et al. 'Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction'.
J Eur Acad Dermatol Venereol
; 34(8): e431-e432, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189381